WDR37 is a cytoplasmic WD40 repeat protein that functions as a stable binding partner of the PACS proteins PACS1 and PACS2, governing ER calcium homeostasis and lymphocyte quiescence (PMID:33630350, PMID:34642815). It homodimerizes and binds PACS1 and PACS2 strongly, with the interaction mediated by a conserved interface within the PACS1 furin-binding region that stabilizes both proteins and is required for their reciprocal expression (PMID:34642815, PMID:41279321). The PACS1–WDR37 complex is required for normal ER Ca2+ handling: loss of either protein produces peripheral lymphopenia with blunted antigen-receptor-triggered Ca2+ release from the ER, diminished IP3 receptor expression, and elevated ER and oxidative stress (PMID:33630350). Disease-associated WDR37 variants act through distinct molecular failures — abolishing PACS binding while sparing dimerization, reducing protein stability, or impairing function in vivo — and in vivo rescue in Drosophila and dominant-negative behavior of missense alleles in zebrafish establish their pathogenicity (PMID:31327508, PMID:31327510, PMID:34642815).